Two Sigma Advisers’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-732,900
| Closed | -$19.8M | – | 2581 |
|
2024
Q2 | $19.8M | Sell |
732,900
-23,100
| -3% | -$625K | 0.04% | 337 |
|
2024
Q1 | $13.8M | Buy |
756,000
+98,600
| +15% | +$1.81M | 0.03% | 430 |
|
2023
Q4 | $8.07M | Buy |
657,400
+232,900
| +55% | +$2.86M | 0.02% | 617 |
|
2023
Q3 | $6.36M | Buy |
424,500
+142,800
| +51% | +$2.14M | 0.02% | 630 |
|
2023
Q2 | $9.15M | Buy |
281,700
+140,100
| +99% | +$4.55M | 0.02% | 520 |
|
2023
Q1 | $5.54M | Buy |
141,600
+129,700
| +1,090% | +$5.08M | 0.01% | 767 |
|
2022
Q4 | $629K | Buy |
+11,900
| New | +$629K | ﹤0.01% | 1782 |
|
2021
Q3 | – | Sell |
-52,700
| Closed | -$2.52M | – | 2732 |
|
2021
Q2 | $2.52M | Sell |
52,700
-2,700
| -5% | -$129K | 0.01% | 1184 |
|
2021
Q1 | $2.81M | Buy |
55,400
+48,300
| +680% | +$2.45M | 0.01% | 1107 |
|
2020
Q4 | $447K | Buy |
+7,100
| New | +$447K | ﹤0.01% | 1909 |
|